You can download and print the educational resources below. They are provided to help your practice and your patients learn about the benefits of GLOPERBA®—the first and only liquid oral colchicine with precision dosing below 0.6 mg for patients with renal impairment or GI sensitivity.1-3
For the office
- Consequences of uncontrolled gout
- ACR guidelines recommendations for colchicine in gout prophylaxis
- Risk of colchicine toxicity in patients with chronic kidney disease or GI sensitivity
- Benefits of precision dosing with GLOPERBA
Patients in need of gout prophylaxis, but at risk for colchicine toxicity, may benefit from precision dosing with GLOPERBA. This easy-to-use guide can help you identify the appropriate GLOPERBA patients in your practice.
This summary highlights the importance of precision dosing and how GLOPERBA can help. It also ensures your practice has easy access to recommended dosing information for patients with moderate-to-severe renal impairment or GI sensitivity.
Accurately prescribing GLOPERBA for at-risk patients is crucial for treatment success. This prescribing guide provides recommended starting doses for different gout patient populations as well as clear, step-by-step instructions on how to enter a GLOPERBA prescription into EMR correctly.
This downloadable cheat sheet serves as a quick reference guide to assist you in remembering how to prescribe GLOPERBA for each patient type.
For Pharmacists
This brochure is designed to educate pharmacists on the benefits of GLOPERBA. It includes a summary of clinical data, key pharmacy ordering details, recommended starting doses for at-risk patients, and an active GLOPERBA co-pay card for immediate patient savings.
For Patients
The patient brochure includes an active co-pay card for immediate patient savings. It also includes a “how to take” guide, ensuring patients successfully start, and properly store, their GLOPERBA therapy.
